Catalent reports second-quarter revenue slightly above estimates
In this article:
Feb 9 (Reuters) - Catalent reported quarterly revenue that came in slightly above Wall Street estimates on Friday, days after the contract drug manufacturer agreed to a $16.5-billion acquisition offer from Novo Nordisk's parent firm.
Revenue for the second quarter was $1.03 billion, compared to analysts' estimate of $1.01 billion, according to LSEG data, helped by improved production across Catalent's key facilities.
(Reporting by Sriparna Roy and Bhanvi Satija in Bengaluru; Editing by Pooja Desai)
